Effect of amino acid substitution of the V3 and bridging sheet residues in human immunodeficiency virus type 1 subtype C gp120 on CCR5 utilization

被引:35
|
作者
Suphaphiphat, P
Thitithanyanont, A
Paca-Uccaralertkun, S
Essex, M
Lee, TH
机构
[1] Harvard Univ, Sch Med, Dept Immunol & Infect Dis, Boston, MA 02115 USA
[2] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok 10400, Thailand
关键词
D O I
10.1128/JVI.77.6.3832-3837.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The V3 loop and the bridging sheet domain of human immunodeficiency virus type 1 (HIV-1) subtype B envelope glycoprotein gp120 have been implicated in CCR5 coreceptor utilization. In this study, mutant envelope glycoproteins of a subtype C isolate containing substitutions in the V3 or C4 region were generated to determine which are required for efficient CCR5-dependent cell fusion and viral entry. We found that the V3 crown and C4 residues are relatively dispensable for cell-cell fusion, although some residues may be involved in the regulation of early postentry steps in viral replication. In contrast, seven highly conserved residues located in the V3 stem are critical for CCR5 utilization, which can explain the apparent paradox that the functional convergence in CCR5 usage by genetically divergent HIV-1 strains involves a variable region. The finding that C4 residues do not have a critical role may appear to contradict the current model that bridging sheet residues are involved in the gp120-CCR5 interaction. However, a plausible interpretation is that these C4 residues may have a distinct role in the binding and fusion steps of the gp120-CCR5 interaction.
引用
收藏
页码:3832 / 3837
页数:6
相关论文
共 50 条
  • [41] MOLECULAR DETERMINANTS OF THE V3 LOOP OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GLYCOPROTEIN GP120 RESPONSIBLE FOR CONTROLLING CELL TROPISM
    CHAVDA, SC
    GRIFFIN, P
    ZHEN, HL
    KEYS, B
    VEKONY, MA
    CANN, AJ
    JOURNAL OF GENERAL VIROLOGY, 1994, 75 : 3249 - 3253
  • [42] NMR structural analysis of the HIV-1 GP120 V3 - CCR5 co-receptor N-terminal interaction
    Galanakis, P. A.
    Kandias, N.
    Spyroulias, G. A.
    Sioumpara, M.
    Morikis, D.
    Rizos, A.
    Krambovitis, E.
    JOURNAL OF PEPTIDE SCIENCE, 2006, 12 : 196 - 196
  • [43] Subtyping of human immunodeficiency virus type 1 strains by using antibodies specific for the third variable domain (V3) of gp120, results may be affected by divergent V3 sequences
    Sherefa, K
    Sallberg, M
    Johansson, B
    Salminen, M
    Sonnerborg, A
    JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (09) : 2419 - 2421
  • [44] Analysis of the HIV-1 gp120 V3 loop at screening for treatment-experienced patients in the MOTIVATE studies who failed with CCR5 tropic virus
    Lewis, M.
    Simpson, P.
    Jubb, B.
    Craig, C.
    Valdez, H.
    Westby, M.
    ANTIVIRAL THERAPY, 2010, 15 : A76 - A76
  • [45] CD4 binding site antibodies inhibit human immunodeficiency virus gp120 envelope glycoprotein interaction with CCR5
    Raja, A
    Venturi, M
    Kwong, P
    Sodroski, J
    JOURNAL OF VIROLOGY, 2003, 77 (01) : 713 - 718
  • [46] Heterosexual Transmission of Human Immunodeficiency Virus Type 1 Subtype C: Macrophage Tropism, Alternative Coreceptor Use, and the Molecular Anatomy of CCR5 Utilization
    Isaacman-Beck, Jesse
    Hermann, Emilia A.
    Yi, Yanjie
    Ratcliffe, Sarah J.
    Mulenga, Joseph
    Allen, Susan
    Hunter, Eric
    Derdeyn, Cynthia A.
    Collman, Ronald G.
    JOURNAL OF VIROLOGY, 2009, 83 (16) : 8208 - 8220
  • [47] UCLA1, a Synthetic Derivative of a gp120 RNA Aptamer, Inhibits Entry of Human Immunodeficiency Virus Type 1 Subtype C
    Mufhandu, Hazel T.
    Gray, Elin S.
    Madiga, Maphuti C.
    Tumba, Nancy
    Alexandre, Kabamba B.
    Khoza, Thandeka
    Wibmer, Constantinos Kurt
    Moore, Penny L.
    Morris, Lynn
    Khati, Makobetsa
    JOURNAL OF VIROLOGY, 2012, 86 (09) : 4989 - 4999
  • [48] Antibody-mediated enhancement of human immunodeficiency virus type 1 infectivity is determined by the structure of gp120 and depends on modulation of the gp120-CCR5 interaction
    Guillon, C
    Schutten, M
    Boers, PHM
    Gruters, RA
    Osterhaus, ADME
    JOURNAL OF VIROLOGY, 2002, 76 (06) : 2827 - 2834
  • [49] Chemokine receptor utilization and macrophage signaling by human immunodeficiency virus type 1 gp120: Implications for neuropathogenesis
    Yi, YJ
    Lee, CH
    Liu, QH
    Freedman, BD
    Collman, RG
    JOURNAL OF NEUROVIROLOGY, 2004, 10 : 91 - 96
  • [50] Chemokine receptor utilization and macrophage signaling by human immunodeficiency virus type 1 gp120: Implications for neuropathogenesis
    Yi Y.
    Lee C.
    Liu Q.-H.
    Freedman B.D.
    Collman R.G.
    Journal of NeuroVirology, 2004, 10 (Suppl 1) : 91 - 96